Ethics, authorship concerns sink homeopathy paper by researchers arrested last year

For a host of reasons, a journal has retracted a paper co-authored by a researcher who reportedly once faced charges of practicing medicine without proper qualifications.

According to the retraction notice for “Psorinum Therapy in Treating Stomach, Gall Bladder, Pancreatic, and Liver Cancers: A Prospective Clinical Study,” published Dec. 8, 2010 in Evidence-Based Complementary and Alternative Medicine, the paper was plagued by:

Continue reading Ethics, authorship concerns sink homeopathy paper by researchers arrested last year

Weekend reads: A new plagiarism euphemism; how Photoshop abuse destroys science; bias against women authors

The week at Retraction Watch featured a look at what happens to authors when a journal is delisted, a reminder of how hard it is to figure out whether a paper has been retracted, and a survey on how common plagiarism is in economics. Here’s what was happening elsewhere: Continue reading Weekend reads: A new plagiarism euphemism; how Photoshop abuse destroys science; bias against women authors

Child took wrong compound for over a year after “communication error”

Credit: Steven Depolo, Flickr

A journal is retracting a paper after it discovered researchers gave a child the wrong supplement for more than a year.

Rhiannon Bugno, managing editor for Biological Psychiatry, told Retraction Watch the mix-up did not put the patient at risk. However, the mistake was enough for the journal’s editor, John Krystal, of Yale University, to request the retraction of a 2016 paper describing the young girl’s experience taking the compound,“Rett-like Severe Encephalopathy Caused by a De Novo GRIN2B Mutation Is Attenuated by D-serine Dietary Supplement.”

Originally published June 17, 2016, the paper was retracted Jan. 15. Led by corresponding author Xavier Altafaj, of the University of Barcelona (UB) and Bellvitge Biomedical Research Institute (IDIBELL), researchers described using an amino acid, D-serine, to treat a child with a rare genetic disorder that affects neurons.

According to the notice, the researchers did use D-serine in lab work used as proof-of-concept; however, when it came time to try it in the patient, as a result of a “communication error:”

Continue reading Child took wrong compound for over a year after “communication error”

Caught Our Notice: Bioethics article retracted for…ethics violation

Title: Bioethics and Medical Education

What Caught Our Attention: As we’ve said before, you can’t make this stuff up: An article on bioethics had its own ethical issues to deal with. It turns out, the authors had “substantial unreferenced overlap” with another article, that “overlap” including the article’s title. Here’s a side by side comparison of the first page, highlighting the matching text: Continue reading Caught Our Notice: Bioethics article retracted for…ethics violation

Oops: Elsevier journal retracts the wrong paper

When Saidur Rahman learned last month that his 2010 review paper about nanoparticles in refrigeration systems had been retracted, he was concernedno one at the journal had told him it was going to be pulled.

Rahman, a professor of engineering at Sunway University in Selangor, Malaysia, had recently corrected his 2010 review in Renewable and Sustainable Energy Reviewsspecifically, in January, the journal published a two-page correction rewriting the parts of the paper that were “appear close to some materials we had included in some of our other review research.” But Rahman was not anticipating a retraction. Continue reading Oops: Elsevier journal retracts the wrong paper

Is plagiarism a problem in economics? Survey of editors says … yes

Gary Hoover

In 2004, a survey of editors of economic journals found 3 out of 10 had seen at least one case of plagiarism within the past year. More than a decade later, has the problem gotten better? Or worse? Gary Hoover at the University of Oklahoma, who co-authored the 2004 paper, decided to revisit the issue by resurveying editors in economics, along with others working in different fields. What he found — and reported in Social Science Quarterly — was plagiarism is still a problem, which economists want to address.

Retraction Watch: Why did you want to revisit the findings from the 2004 survey of editors in economics 10 years later?

Continue reading Is plagiarism a problem in economics? Survey of editors says … yes

Data in biofuel paper “had either been grossly misinterpreted or fabricated”

A biology journal has retracted a 2011 paper after the University of California, Los Angeles determined that the data in three figures “cannot be supported.”

In February, the journal Applied and Environmental Microbiology retracted the paper, which explores efforts to engineer bacteria to convert plant biomass into biofuel.

Claudia Modlin, assistant director of UCLA’s Office of Research Policy and Compliance, told Retraction Watch that the university informed the journal about the issues last October, after reviewing the work. Continue reading Data in biofuel paper “had either been grossly misinterpreted or fabricated”

Want to tell if a paper has been retracted? Good luck

Caitlin Bakker

Nowadays, there are many ways to access a paper — on the publisher’s website, on MEDLINE, PubMed, Web of Science, Scopus, and other outlets. So when the publisher retracts a paper, do these outlets consistently mark it as such? And if they don’t, what’s the impact? Researchers Caitlin Bakker and Amy Riegelman at the University of Minnesota surveyed more than one hundred retractions in mental health research to try to get at some answers, and published their findings in the Journal of Librarianship and Scholarly Communication. We spoke to Bakker about the potential harm to patients when clinicians don’t receive consistent notifications about retracted data.

Retraction Watch: You note: “Of the 144 articles studied, only 10 were represented as being retracted across all resources through which they were available. There was no platform that consistently met or failed to meet all of [the Committee on Publication Ethics (COPE)’s] guidelines.” Can you say more about these findings, and the challenges they may pose?

Continue reading Want to tell if a paper has been retracted? Good luck

Caught Our Notice: No retraction for “likely fraudulent” study

Title: Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson’s disease

What Caught Our Attention:  In a letter to the editor, researchers led by Mark Bolland recently outlined the many reasons why a study by Yoshihiro Sato and colleagues in The American Journal of Medicine was “unreliable,” including evidence that the patient numbers were not achievable as described, and inconsistencies and errors in the study data. And let’s not forget a 2016 analysis (co-authored by Bolland) which cast doubt on Sato’s body of work, suggesting that more than 30 of his papers could be problematic. Continue reading Caught Our Notice: No retraction for “likely fraudulent” study

When a journal is delisted, authors pay a price

Shocked, confused, disappointed — these are the reactions of authors who recently published in a cancer journal that was delisted by a company that indexes journals.

Recently, Clarivate Analytics announced it would discontinue indexing Oncotarget after the first few issues of 2018 — as a result, the journal would not receive a current impact factor. The company did not tell us a specific reason why, simply saying it “no longer meets the standards necessary for continued coverage.” Last year, the journal was also removed from the U.S. government biomedical research database MEDLINE, also with no explanation. (At the time, the National Library of Medicine’s Associate Director for Library Operations told us readers who are familiar with the guidelines MEDLINE follows when deselecting journals “can draw their own conclusions” as to why Oncotarget was removed.)

After we covered Clarivate’s decision to delist Oncotarget, many posted comments on the story, including suggestions the move could hurt authors who submitted papers before the announcement. (Some comments also appeared to be versions of the same request that the journal be indexed through January 15.)

We reached out to many of the corresponding authors on papers in the January 26 issue, the seventh issue published in 2018. Many are based at leading institutions around the world; all had submitted their manuscripts months ago. Some noted that they were surprised by the decision, as the review process appeared quite rigorous; some told us that if they’d known the journal was going to be delisted, they would not have submitted their papers there.

Continue reading When a journal is delisted, authors pay a price